Christian Damblon

Christian Damblon

Auto-generated profile, based on publicly available information

Christian Damblon

MolSys Research Unit, Faculty of Sciences, University of Liege, Belgium

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 February 2023 in Heliyon
Verified
Journal Article
Open access
GCGilles Cremer
Gilles Cremer
Sabine DanthineSabine Danthine
Sabine Danthine
VHVera Van Hoed
Vera Van Hoed
ADAnne Dombree
Anne Dombree
ALAnne-Sophie Laveaux
Anne-Sophie Laveaux
CBChristophe Blecker
Christophe Blecker
Hydroxypropyl cellulose (HPC) is a water-soluble polymer with many applications in food, pharmaceutical, medical, or paints industries. Past studies have reported that differences in functionality can occur between products of similar pharmaceutical grades. Understanding the origin of these differences is a major challenge for the industry. In this work, the structure and physico-chemical properties of several HPC samples of the same commercial grade were studied. Structural analysis by NMR and enzymatic hydrolysis were performed to study molar substitution and distribution of substituents along the polymer chain respectively. Water-polymer interactions, surface properties as well as rheological and thermal behavior were characterized to tentatively correlate them with the structure, and gain new insights into the structure-function relationship of this polymer. The differences in structure revealed between the samples affect their properties. The unexpected behavior of one sample was attributed to a more heterogeneous substitution pattern, with the coexistence of highly and weakly substituted regions along the same polymer chain. The more block-like distribution of substituents has a great effect on the clouding behavior and surface tension reduction ability of the polymer.

16 November 2026 in Journal of Molecular Biology
Verified
Journal Article
Closed access
RMRomain Malempré
Romain Malempré
JVJulie Vandenameele
Julie Vandenameele
CMCaroline Montagner
Caroline Montagner
CRChristina Redfield
Christina Redfield
CDChristian Damblon
Christian Damblon
AMAndré Matagne
André Matagne

25 August 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
EMEsther Lita Morsia
Esther Lita Morsia
CTCyrille Ngoufack Tagousop
Cyrille Ngoufack Tagousop
SFSiméon Pierre Chegaing Fodouop
Siméon Pierre Chegaing Fodouop
JYJoël Abel Gbaweng Yaya
Joël Abel Gbaweng Yaya
JDJudith Djouakoua Djithe
Judith Djouakoua Djithe
CDChristian Damblon
Christian Damblon
Ethnopharmacological relevance: Bombax costatum Pellegr. & Vuillet (Malvaceae) is widely used in african traditional medicine for management of bacterial infections. The escalating antimicrobial resistance crisis drives the exploration of medicinal plants as alternative reservoirs for novel therapeutics and antibiotic adjuvants.Aim of the study: This study evaluates the in vitro antibacterial efficacy and modifying potential of extracts and isolated compounds from Bombax costatum (Malvaceae) in combination with ciprofloxacin (CIP).Materials and Methods: Ethanol extracts from various Bombax costatum organs (stem bark, fruits, leaves and roots) were screened against six pathogenic bacterial strains using the broth microdilution method. Chromatographic fractionation of the crude fruit extract (FBC) yielded eight compounds, with mangiferin (1) and quercetin-3-O-β-D-glucopyranoside (2) selected for further evaluation. Pharmacodynamic interactions between CIP, FBC, and the isolated compounds were quantitatively assessed via checkerboard microdilution assays to determine the Fractional Inhibitory Concentration Index (FICI).Results: Baseline testing against a panel of pathogens including Escherichia coli, Staphylococcus aureus, and Enterobacter revealed that the FBC extract was highly active against E. coli (MIC = 15.65 µg/mL), while compound 2 displayed notable inhibitory action against S. aureus (MIC = 15.65 µg/mL). The checkerboard pharmacodynamic analysis revealed highly favorable profiles completely devoid of antagonistic behavior. Notably, combining ciprofloxacin with Compound 1 induced a significant additive effect (FICI = 0.5) against S. aureus and Enterobacter, triggering a fourfold reduction in the antibiotic's MIC. Similarly, the crude fruit extract (FBC) acted additively when paired with ciprofloxacin (FICI = 0.5), effectively reducing the required inhibitory concentration of the conventional drug against E. coli and Enterobacter.Conclusion: These findings firmly validate the ethnopharmacological relevance of B. costatum and highlight the potential of its phytoconstituants to serve as effective resistance-modifying adjuvants in fluoroquinolone-based therapies.